Purpose <p>The clinical relevance of the red blood cell distribution width (RDW) in patients with distal cholangiocarcinoma (DCC) undergoing pancreaticoduodenectomy (PD) has not been clearly investigated.</p> Methods <p>The relationship between the preoperatively measured RDW and prognosis for the recurrence/survival was evaluated in patients with DCC undergoing PD. A subgroup analysis was also performed in patients with pathological stage I DCC.</p> Results <p>A total of 77 patients were included in the analysis. The cutoff value of the preoperatively measured RDW was set at 14%, and the normal reference range at our center was ≤ 14%. The patient group with an RDW &gt; 14% (<i>n</i> = 30) had a significantly lower mean serum albumin level, higher mean serum carbohydrate antigen 19–9 level, and a higher proportion of cases with pathological lymphatic invasion and showed a significantly worse overall survival than the patient group with an RDW ≤ 14% (<i>n</i> = 47). Similar findings were noted in both the overall study population and patients with pathological stage I disease. Multivariate analysis identified an RDW &gt; 14% and pathological lymph node metastasis as independent risk factors for a poor postoperative survival.</p> Conclusion <p>The preoperatively measured RDW is a promising prognostic predictor in patients with DCC undergoing PD.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Clinical relevance of the red blood cell distribution width measured preoperatively as a prognostic marker in patients with distal cholangiocarcinoma undergoing pancreaticoduodenectomy

  • Maiko Niki,
  • Shozo Mori,
  • Shotaro Miyashita,
  • Tomoaki Hayakawa,
  • Genki Tanaka,
  • Takayuki Shimizu,
  • Takamune Yamaguchi,
  • Kyung-Hwa Park,
  • Takayuki Shiraki,
  • Takatsugu Matsumoto,
  • Taku Aoki

摘要

Purpose

The clinical relevance of the red blood cell distribution width (RDW) in patients with distal cholangiocarcinoma (DCC) undergoing pancreaticoduodenectomy (PD) has not been clearly investigated.

Methods

The relationship between the preoperatively measured RDW and prognosis for the recurrence/survival was evaluated in patients with DCC undergoing PD. A subgroup analysis was also performed in patients with pathological stage I DCC.

Results

A total of 77 patients were included in the analysis. The cutoff value of the preoperatively measured RDW was set at 14%, and the normal reference range at our center was ≤ 14%. The patient group with an RDW > 14% (n = 30) had a significantly lower mean serum albumin level, higher mean serum carbohydrate antigen 19–9 level, and a higher proportion of cases with pathological lymphatic invasion and showed a significantly worse overall survival than the patient group with an RDW ≤ 14% (n = 47). Similar findings were noted in both the overall study population and patients with pathological stage I disease. Multivariate analysis identified an RDW > 14% and pathological lymph node metastasis as independent risk factors for a poor postoperative survival.

Conclusion

The preoperatively measured RDW is a promising prognostic predictor in patients with DCC undergoing PD.